Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2017 Jul;152(1):22-31.
doi: 10.1016/j.chest.2017.01.010. Epub 2017 Jan 19.

Endothelial Permeability and Hemostasis in Septic Shock: Results From the ProCESS Trial

Peter C Hou  1 , Michael R Filbin  2 , Henry Wang  3 , Long Ngo  4 , David T Huang  5 , William C Aird  6 , Donald M Yealy  7 , Derek C Angus  5 , John A Kellum  5 , Nathan I Shapiro  8 ; ProCESS Investigators(∗)
Affiliations
Randomized Controlled Trial

Endothelial Permeability and Hemostasis in Septic Shock: Results From the ProCESS Trial

Peter C Hou et al. Chest. 2017 Jul.

Abstract

Background: We studied patients from the Protocolized Care in Early Septic Shock (ProCESS) trial to determine the effects of alternative resuscitation strategies on circulating markers of endothelial cell permeability and hemostasis and the association between biomarkers and mortality.

Methods: This was a prospective study of biomarkers of endothelial cell permeability (vascular endothelial growth factor [VEGF], soluble fms-like tyrosine kinase 1 [sFLT-1], angiopoietin 2 [Ang-2]) and biomarkers of hemostasis (von Willebrand factor [vWF], thrombomodulin [TM], tissue plasminogen activator [tPA] in 605 of the 1,341 ProCESS participants in a derivation cohort and 305 participants in a validation cohort. Analyses assessed (1) the impact of varying resuscitation strategies on biomarker profiles and (2) the association of endothelial biomarkers with 60-day in-hospital mortality. The study was conducted in 31 US EDs in adult patients with septic shock. Patients were randomly assigned to one of three resuscitation strategies. Blood samples were collected at enrollment, at 6 h, and at 24 h.

Results: There were 116 (19.2%) and 52 (17.0%) deaths in the derivation and validation cohorts, respectively. There was no significant association between treatment strategy and any biomarker levels. Permeability (Ang-2 and sFLT-1) and hemostasis (vWF, TM, tPA) biomarkers were higher and VEGF levels were lower in nonsurvivors (P < .05 for all). At baseline, sFLT-1 had the highest point estimate for mortality discrimination (derivation area under the curve [AUC], 0.74; validation, 0.70), similar to lactate (AUC, 0.74) and Sequential Organ Failure Assessment score (AUC, 0.73). In an analysis including all time points and adjusted for age, presence of cancer, and Charlson comorbidity score, the adjusted AUC for sFLT-1 was 0.80.

Conclusions: We found no relationship between different resuscitation strategies and biomarker profiles in sepsis, but we did find that elevated levels of endothelial cell biomarkers of permeability and hemostasis were associated with increased mortality.

Trial registry: ClinicalTrials.gov; No.: NCT00510835 and NCT00793442; URL: www.clinicaltrials.gov.

Keywords: biomarkers; endothelium; hemostasis; permeability; sepsis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Mean log-transformed biomarker levels with 95% CIs stratified by survivors and nonsurvivors (60-day in-hospital mortality). Ang = angiopoietin; sFLT-1 = soluble fms-like tyrosine kinase 1; TMB = thrombomodulin; tPA = tissue plasminogen activator; vWF = von Willebrand factor.
See this image and copyright information in PMC

Comment in

References

    1. Angus D.C., Linde-Zwirble W.T., Lidicker J., Clermont G., Carcillo J., Pinsky M.R. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29(7):1303–1310. - PubMed
    1. Aird W.C. The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood. 2003;101(10):3765–3777. - PubMed
    1. Shapiro N.I., Schuetz P., Yano K. The association of endothelial cell signaling, severity of illness, and organ dysfunction in sepsis. Crit Care. 2010;14(5):R182. - PMC - PubMed
    1. Boldt J., Muller M., Kuhn D., Linke L.C., Hempelmann G. Circulating adhesion molecules in the critically ill: a comparison between trauma and sepsis patients. Intensive Care Med. 1996;22(2):122–128. - PubMed
    1. Yano K., Liaw P.C., Mullington J.M. Vascular endothelial growth factor is an important determinant of sepsis morbidity and mortality. J Exp Med. 2006;203(6):1447–1458. - PMC - PubMed

Publication types

MeSH terms

Associated data